Matinas BioPharma Holdings (MTNB) Current Leases (2014 - 2026)
Matinas BioPharma Holdings (MTNB) reported Current Leases of $1,000 for Q2 2026, down 80.0% from $5,000 a year earlier and down 50.0% from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Current Leases (2014 - 2026) Analysis & Trends
At the end of FY2025, Matinas BioPharma Holdings posted Current Leases of $2,000, down 60.0% from FY2024.
- Current Leases has a five-year compound annual growth rate of -42.1% (FY2020 to FY2025).
- By year, Current Leases came in at $5,000 in FY2024 (unchanged), $5,000 in FY2023 (-28.6%), $7,000 in FY2022 (-66.7%) and $21,000 in FY2021 (-31.9%).
- The Q2 2026 figure ranks as the lowest quarterly Current Leases in data going back to Q1 2014.
- Year over year, Current Leases has now declined in each of the last three quarters, with an average decline of 23.3% over the last eight quarters.
- The high point for year-over-year Current Leases in five years was Q1 2024 (growth of 25.0%); the low point was Q2 2026 (a decline of 80.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2,000 (Q1 2026), $2,000 (Q4 2025) and $5,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 274.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -2.32 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Matinas BioPharma Holdings | 16.27 Mn | 3.68 Mn | - | 1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,860.00 |
| Jun 30, 2022 | 11,508.00 |
| Mar 31, 2022 | 17,134.00 |
| Dec 31, 2021 | 21,000.00 |
| Sep 30, 2021 | 24,309.00 |
API Access
Matinas BioPharma Holdings Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();